Search Results - "Bouwer, N. I."

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
  2. 2

    Radiological complete remission in HER2-positive metastatic breast cancer patients: what to do with trastuzumab? by Steenbruggen, T. G., Bouwer, N. I., Smorenburg, C. H., Rier, H. N., Jager, A., Beelen, K., ten Tije, A. J., de Jong, P. C., Drooger, J. C., Holterhues, C., Kitzen, J. J. E. M., Levin, M. -D., Sonke, G. S.

    Published in Breast cancer research and treatment (01-12-2019)
    “…Purpose Patients with HER2-positive metastatic breast cancer (MBC) treated with trastuzumab may experience durable tumor response for many years. It is unknown…”
    Get full text
    Journal Article
  3. 3

    2D-echocardiography vs cardiac MRI strain using deep learning: a prospective cohort study in patients with HER2-positive breast cancer undergoing trastuzumab by Bouwer, NI, Liesting, C, Kofflard, MJM, Brugts, JJ, Kock, MCJ, Kitzen, JJEM, Levin, M-D, Boersma, E

    “…Abstract Funding Acknowledgements Type of funding sources: Private hospital(s). Main funding source(s): Promotiefonds Albert Schweitzer Hospital Background…”
    Get full text
    Journal Article
  4. 4

    Abstract P6-17-19: What to do with trastuzumab therapy after achieving radiological complete remission (rCR) in HER2+ metastatic breast cancer (MBC)? by Steenbruggen, TG, Bouwer, NI, Smorenburg, CH, Rier, HN, Jager, A, Beelen, KJ, ten Tije, AJ, de Jong, PC, Drooger, JC, Holterhues, C, Horlings, HM, Sanders, J, Levin, M-D, Sonke, GS

    Published in Cancer research (Chicago, Ill.) (15-02-2019)
    “…Abstract Intro MBC is generally considered incurable, but patients with HER2+ disease treated with trastuzumab do relatively well and some have an exceptional…”
    Get full text
    Journal Article